We have located links that may give you full text access.
Evidence-Based Patient Selection in Headache Surgery: The Impact of Preoperative RFA Treatment on Surgical Outcomes.
Plastic and Reconstructive Surgery 2022 December 24
BACKGROUND: Radiofrequency ablation (RFA) of the greater occipital nerve (GON) is a minimally- invasive treatment option commonly used in patients with occipital neuralgia. Patients who undergo occipital surgery for headaches after failed RFA treatment present a unique opportunity to evaluate RFA- treated occipital nerves and determine the impact on headache surgery outcomes.
METHODS: Of 115 patients who underwent headache surgery at the occipital site, twenty- nine had a history of prior RFA treatment. Migraine Headache Index, Pain Self- Efficacy Questionnaire, and Pain Health Questionnaire- 2 outcome scores were recorded preoperatively and at follow- up visits. Intraoperative macroscopic nerve damage and surgical outcomes were compared between RFA and non- RFA patients.
RESULTS: RFA- treated patients had a higher rate of macroscopic nerve damage (45%) than non RFA- treated patients (24%) (p= 0.03), and were significantly more likely to require a second surgery at the site of primary decompression (27.6% versus 5.8%; p= 0.001), as well as GON transection (13.8% versus 3.5%; p= 0.04). Outcome scores at the last follow up visit showed no statistically significant difference between RFA- treated and non RFA- treated patients (p= 0.96).
CONCLUSION: RFA patients can ultimately achieve outcomes that are not significantly different from non- RFA patients in occipital headache surgery. However, a higher number of secondary surgery at the site of primary decompression and nerve transections are required to treat refractory symptoms. RFA- treated patients should be counselled about an increased risk of same-site surgery and possible GON transection to achieve acceptable outcomes.
METHODS: Of 115 patients who underwent headache surgery at the occipital site, twenty- nine had a history of prior RFA treatment. Migraine Headache Index, Pain Self- Efficacy Questionnaire, and Pain Health Questionnaire- 2 outcome scores were recorded preoperatively and at follow- up visits. Intraoperative macroscopic nerve damage and surgical outcomes were compared between RFA and non- RFA patients.
RESULTS: RFA- treated patients had a higher rate of macroscopic nerve damage (45%) than non RFA- treated patients (24%) (p= 0.03), and were significantly more likely to require a second surgery at the site of primary decompression (27.6% versus 5.8%; p= 0.001), as well as GON transection (13.8% versus 3.5%; p= 0.04). Outcome scores at the last follow up visit showed no statistically significant difference between RFA- treated and non RFA- treated patients (p= 0.96).
CONCLUSION: RFA patients can ultimately achieve outcomes that are not significantly different from non- RFA patients in occipital headache surgery. However, a higher number of secondary surgery at the site of primary decompression and nerve transections are required to treat refractory symptoms. RFA- treated patients should be counselled about an increased risk of same-site surgery and possible GON transection to achieve acceptable outcomes.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app